Cargando…
Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study
PURPOSE: Safety data of many drugs used during pregnancy remain scarce. This is especially true in developing countries characterised by the absence of a robust pharmacovigilance system, high prevalence of different tropical diseases affecting patients and potential for drug-drug interactions. This...
Autores principales: | Rouamba, Toussaint, Valea, Innocent, Bognini, Joel D., Kpoda, Herve, Mens, Petra F., Gomes, Melba F., Tinto, Halidou, Kirakoya-Samadoulougou, Fati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119166/ https://www.ncbi.nlm.nih.gov/pubmed/30155832 http://dx.doi.org/10.1007/s40801-018-0141-1 |
Ejemplares similares
-
Asymptomatic malaria and anaemia among pregnant women during high and low malaria transmission seasons in Burkina Faso: household-based cross-sectional surveys in Burkina Faso, 2013 and 2017
por: Rouamba, Toussaint, et al.
Publicado: (2021) -
Bayesian Spatiotemporal Modeling of Routinely Collected Data to Assess the Effect of Health Programs in Malaria Incidence During Pregnancy in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2020) -
Severe-malaria infection and its outcomes among pregnant women in Burkina Faso health-districts: Hierarchical Bayesian space-time models applied to routinely-collected data from 2013 to 2018
por: Rouamba, Toussaint, et al.
Publicado: (2020) -
How to Estimate Optimal Malaria Readiness Indicators at Health-District Level: Findings from the Burkina Faso Service Availability and Readiness Assessment (SARA) Data
por: Rouamba, Toussaint, et al.
Publicado: (2020) -
Addressing challenges in routine health data reporting in Burkina Faso through Bayesian spatiotemporal prediction of weekly clinical malaria incidence
por: Rouamba, Toussaint, et al.
Publicado: (2020)